Skip navigation

BMO donates $2 million to the McGill University Health Centre Foundation for precision cancer care

December 10, 2021 | Giving and sponsorships

BMO is proud to help transform the future of cancer treatment with a $2 million donation to the McGill University Health Centre (MUHC) Foundation. The gift will help cancer experts at the Research Institute of the McGill University Health Centre (RI-MUHC) develop the hospital’s precision oncology program with personalized treatment tailored to each patient.

Precision oncology means providing the right treatment to the right patient at the right time. Using advanced tools and techniques, the MUHC’s oncologists can understand exactly what type of cancer a patient has and they can test treatment options in the laboratory to ensure they have the optimal effect.

“Precision oncology is the future of cancer care. It decreases use of one-size-fits-all treatments in favour of a personalized approach to each patient’s disease. We are incredibly grateful to BMO for supporting the development of the Precision Oncology Program at the Research Institute of the MUHC.”

­– Dr. Rhian Touyz, Executive Director and Chief Scientific Officer, RI-MUHC

BMO’s gift will support a range of specialized techniques, including creation of organoids, patient tumours and tissue grown in the lab. Organoids allow the MUHC’s oncologists to test treatments externally before administering them to the patient. This helps ensure each patient receives the optimal treatment right away, avoiding excessive or unnecessary therapies.

“At BMO, we believe that the strongest progress can be made through collaborative and innovative approaches to solving complex problems. We’re proud to help grow the good in Montreal – and beyond – with this investment in the MUHC’s Precision Oncology Program that will pioneer new cancer treatments, leading to transformational change in healthcare for all Canadians.”

Darryl White, Chief Executive Officer, BMO

The gift is part of the MUHC Foundation’s $20 million campaign to End Cancer as a deadly disease. A priority of the $200 million Dream Big Campaign to change the course of lives and medicine, End Cancer is helping pioneer new cancer treatments, improve patient care and ensure more people survive.

Learn more about BMO’s recent donations.

Related Insights